Chronic Refractory Cough Therapy Market

View All

mercks-gefapixant-for-crc-treatment
Will Merck’s P2X3 Receptor Antagonist for Chronic Refractory Cough Treatment Be Able to Turn FDA’s Nay Into Yea?

Patients who are battling this crippling ailment find that chronic refractory cough (CRC), also known as refractory chronic cough (RCC) or unexplained chronic cough (UCC), proves to be a major burden. DelveInsight’s analysis estimates that in the US, there were approximately 12.7 million 12-month prevalent episodes...

Find More

Chronic Refractory Cough Market | Chronic refractory cough Treatment
Chronic Refractory Cough Market and the Monopoly of the Over-The-Counter Drugs

Cough! Cough! Every time something goes down the wrong pipe, we cough it out. Within seconds, it gets normal. We catch flu, or cold, cough accompanies for a week or two. However, what if cough decides to befriend the person for a time period more than usual, say, around eight weeks or more? It can be worrisome, and...

Find More

Chronic Refractory Cough Market landscape
Chronic Refractory Cough Market landscape: A new approach to treating cough

When cough seems everlasting, mortifying, and excruciating, it is high time to consult a physician as you might be stricken by chronic cough, which can be irritating and may also lead to nagging cough and a throbbing headache. Although chronic cough is not usually severe, it can be very annoying. Chronic Refractory...

Find More